Workshop questions on Fludarabine

[Guest guest]

* Is the risk/benefit profile for fludarabine-based protocols different

for initial treatment versus second-line use?

* Or put similiarly: Do most experts prescribe or recommend F-based

protocols for first or second line use?

* Should Fludarabine be used mainly when treating aggressively? ... not

used routinely as a single agent as a management approach?

* Are there different answers to the above questions for cLL versus

indolent NHL?

Thanks

~ Karl